Seroprevalence and risk factors for human herpesvirus 8 infection, rural egypt

被引:16
|
作者
Mbulaiteye, Sam M. [1 ]
Pfeiffer, Ruth M. [1 ]
Dolan, Bryan [1 ]
Tsang, Victor C. W. [5 ]
Noh, John [5 ]
Mikhail, Nabiel N. H. [6 ]
Abdel-Hamid, Mohamed [3 ,4 ]
Hashem, Mohamed [3 ,4 ]
Whitby, Denise [2 ]
Strickland, G. Thomas [3 ]
Goedert, James J. [1 ]
机构
[1] NCI, Rockville, MD USA
[2] NCI, Frederick, MD 21701 USA
[3] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[4] Natl Hepatol & Trop Med Res Inst, Cairo, Egypt
[5] Ctr Dis Control & Prevent, Atlanta, GA USA
[6] Assiut Univ, Cairo, Egypt
关键词
D O I
10.3201/eid1404.070935
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine whether human herpesvirus 8 (HHV-8) is associated with schistosomal and hepatitis C virus infections in Egypt, we surveyed 965 rural household participants who had been tested for HHV-8 and schistosomal infection (seroprevalence 14.2% and 68.6%, respectively, among those <15 years of age, and 24.2% and 72.8%, respectively, among those 2:15 years of age). Among adults, HHV-8 seropositivity was associated with higher age, lower education, dental treatment, tattoos, >10 lifetime injections, and hepatitis C virus seropositivity. In adjusted analyses, HHV-8 seropositivity was associated with dental treatment among men (odds ratio [OR] 2.4, 95% confidence interval [CI] 1.1-5.2) and hepatitis C virus seropositivity among women (OR 3.3, 95% Cl 1.4-7.9). HHV-8 association with antischistosomal antibodies was not significant for men (OR 2.1, 95% CI 0.3-16.4), but marginal for women (OR 1.5, 95% Cl 1.0-2.5). Our findings suggest salivary and possible nosocomial HHV-8 transmission in rural Egypt.
引用
收藏
页码:586 / 591
页数:6
相关论文
共 50 条
  • [1] Seroprevalence of human herpesvirus 8 infection in northern Thailand
    Chen, N
    Nelson, KE
    Jenkins, FJ
    Suriyanon, V
    Duerr, A
    Costello, C
    Robison, V
    Jacobson, LP
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 1052 - 1058
  • [2] Low seroprevalence of human herpesvirus 8 infection in Croatia
    Rode, OD
    Lepej, SZ
    Begovac, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (08) : 1208 - 1208
  • [3] Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon
    Rezza, G
    Tchangmena, OB
    Andreoni, M
    Bugarini, R
    Toma, L
    Bakary, DK
    Glikoutou, M
    Sarmati, L
    Monini, P
    Pezzotti, P
    Ensoli, B
    [J]. SEXUALLY TRANSMITTED DISEASES, 2000, 27 (03) : 159 - 164
  • [4] Seroprevalence of human herpesvirus type 8 infection in patients with lung carcinoma
    Tsao, Shih-Ming
    Lai, Chun-Liang
    Lin, Ming Nan
    Su, Cheng-Chuan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [5] Human herpesvirus 8 seroprevalence in Sardinia
    Serraino, D
    Songini, M
    Bottazzo, GF
    De Paoli, P
    Tedeschi, R
    Franceschi, S
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (13) : 1012 - 1013
  • [6] Human Herpesvirus 8 Seroprevalence, China
    Zhang, Tiejun
    Shao, Xiaodan
    Chen, Yue
    Zhang, Tao
    Minhas, Veenu
    Wood, Charles
    He, Na
    [J]. EMERGING INFECTIOUS DISEASES, 2012, 18 (01) : 150 - 152
  • [7] Human herpesvirus 8 (HHV-8) infection in healthy urban employees from Greece: Seroprevalence and associated factors
    Zavitsanou, Assimina
    Sypsa, Vana
    Petrodaskalaki, Maria
    Kalapothaki, Victoria
    Whitby, Denise
    Hatzakis, Angelos
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (05) : 591 - 596
  • [8] Seroprevalence and risk factors for C. burentii infection in camels in Egypt
    Selim, Abdelfattah
    Ali, Abdel-Fattah
    [J]. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2020, 68
  • [9] Seroprevalence and risk factors for Neospora spp. infection in equine in Egypt
    Ayed Alshammari
    Hattan S. Gattan
    Mohamed Marzok
    Abdelfattah Selim
    [J]. Scientific Reports, 13
  • [10] Seroprevalence and risk factors for Neospora spp. infection in equine in Egypt
    Alshammari, Ayed
    Gattan, Hattan S.
    Marzok, Mohamed
    Selim, Abdelfattah
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)